Pharmacy, Pharmaceutical Sciences, and Administration at DeSales University

Pennsylvania's pharmaceutical sciences programs typically produce stronger first-year earnings than the $49,444 estimated for comparable programs to DeSales—the state median sits at $57,889, nearly $8,500 higher. That gap matters when you're carrying debt, even if the estimated $24,000 burden here falls within the typical range for similar programs nationally. The debt-to-earnings ratio of 0.49 suggests manageable repayment, but the earnings figure raises questions about whether graduates are landing the same pharmaceutical industry positions as peers at other Pennsylvania schools.

The challenge is that pharmaceutical sciences can mean different things—some bachelor's programs feed directly into pharmacy technician roles or pharmaceutical sales, while others serve primarily as pre-pharmacy prerequisites before students continue to doctoral programs. Without knowing which path DeSales graduates typically follow, it's difficult to assess whether these peer-based estimates reflect good or disappointing outcomes. The $8,500 earnings gap compared to the Pennsylvania median could indicate a different career trajectory entirely rather than underperformance.

For parents considering this investment, the critical question is what happens after graduation. If your child plans to apply to pharmacy school (PharmD programs), the bachelor's outcomes matter less than acceptance rates and prerequisite preparation. If they're stopping at the bachelor's level, you need clarity from DeSales about typical job placements and whether their graduates actually match these national estimates or trend closer to Pennsylvania's stronger median.